TotalMarketCap

Parabilis Medicines

PBLSNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.407 B

$27.94 -7.97%

Close of 6 Nov 2026

As of 6 Nov 2026, Parabilis Medicines (PBLS) has a market capitalization of $3.41B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

121,938,652

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #67Amylyx PharmaceuticalsAMLX$3.48B
  2. #68Arcutis BiotherapeuticsARQT$3.42B
  3. #69Parabilis MedicinesPBLS$3.41B
  4. #70Viking TherapeuticsVKTX$3.29B
  5. #71Enliven TherapeuticsELVN$3.28B

What if Parabilis Medicines were worth as much as…

Open the what-if tool →

Gold $28.2T

$231,540.83

Per share 8,287× higher

Bitcoin $1.53T

$12,528.27

Per share 448× higher

Apple $5.02T

$41,129.14

Per share 1,472× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Parabilis Medicines are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.